Outcomes and complications with off-label use of drug-eluting stents: results from the STENT (Strategic Transcatheter Evaluation of New Therapies) group.
Brodie BR, Stuckey T, Downey W, Humphrey A, Bradshaw B, Metzger C, Hermiller J, Krainin F, Juk S, Cheek B, Duffy P, Smith H, Edmunds J, Varanasi J, Simonton CA; STENT (Strategic Transcatheter Evaluation of New Therapies) Group.
JACC Cardiovasc Interv. 2008 Aug;1(4):405-14. Erratum in: JACC Cardiovasc Interv. 2008 Oct;1(5):601. PMID: 19463338 [PubMed - indexed for MEDLINE]Related articles